Roche's Breakthrough Blood Test for Measuring Lipoprotein(a) Levels to Assess Cardiovascular Risk
Roche's Tina-quant Lp(a) RxDx assay, a blood test that measures lipoprotein(a) levels, has received breakthrough device designation from the FDA to identify adults with elevated Lp(a) who may benefit from emerging lipid-lowering therapies.